Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in New Jersey, automatically classified by Maddy, our AI policy reader.

Total bills
52
2026-2027 Regular Session
Top supporter
Maureen Rowan
100% support rate
Top opponent
Bob Auth
6% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in New Jersey

Legislators moving healthcare in New Jersey
Legislator Party Stance Support rate Decisive votes
Maureen Rowan
Maureen Rowan House · District 2
D
Strong +
100% 15
Jim Beach
Jim Beach Senate · District 6
D
Strong +
100% 14
Marisa Sweeney
Marisa Sweeney House · District 25
D
Strong +
100% 14
Anthony Angelozzi
Anthony Angelozzi House · District 8
D
Strong +
100% 13
Dave Bailey
Dave Bailey House · District 3
D
Strong +
100% 13
Bob Auth
Bob Auth House · District 39
R
Strong −
6% 18
John DiMaio
John DiMaio House · District 23
R
Strong −
10% 10
Paul Kanitra
Paul Kanitra House · District 10
R
Strong −
10% 10
Erik Peterson
Erik Peterson House · District 23
R
Strong −
12% 17
Joe Pennacchio
Joe Pennacchio Senate · District 26
R
Strong −
13% 15
Showing 31–40 of 52 bills

All healthcare bills

passed · New Jersey · General Assembly May 18, 2026

A 2733: Requires emergency departments to provide certain information to parents of children experiencing mental health crisis.

Bill A 2733 requires emergency departments in New Jersey general hospitals to provide parents or guardians of children experiencing mental health crises with contact information for nearby county-based care management organizations (CMOs). These CMOs are defined as nonprofit groups offering in-person support for youth with complex needs and their families. The bill mandates that hospitals share this specific information during emergency visits, directly affecting parents/guardians, emergency departments, and CMOs. It takes effect 90 days after enactment.
passed · New Jersey · General Assembly May 18, 2026

A 1502: "Patient and Provider Protection Act."

This bill regulates pharmacy benefits managers (PBMs) and insurance carriers to increase transparency and fairness in prescription drug coverage. It requires carriers and PBMs to establish pharmacy and therapeutics committees with strict conflict-of-interest rules, prohibits commission-based PBM compensation (mandating flat fees instead), and mandates detailed reporting of PBM fees for insurance filings. The law directly affects insurers, PBMs, and pharmacies by changing how drug formularies (approved drug lists) are managed and how PBM costs are calculated and disclosed. Key provisions include banning preferential formulary placement for higher-cost drugs over lower-cost generics/biosimilars and requiring actuarial documentation for PBM compensation. The bill aims to reduce patient cost-sharing and ensure PBM compensation aligns with administrative costs.
passed · New Jersey · General Assembly May 18, 2026

A 2739: Prohibits social media platforms from promoting certain practices or features of eating disorders to child users.

This bill would prohibit social media platforms from promoting content related to eating disorders - such as diet products, extreme weight loss practices, or harmful eating behaviors - to users under 18. Platforms must conduct quarterly internal audits and annual independent audits to ensure their algorithms or features don’t contribute to eating disorders in children, and fix any issues within 30 days if identified. Small platforms with less than $100 million in annual revenue are exempt from the audit requirements. The bill does not hold platforms liable for user-generated content unless the platform paid to promote it (e.g., via advertisements).
in committee · New Jersey · General Assembly May 14, 2026

A 4657: Requires pharmacy benefits managers to make certain disclosures to health benefits plan sponsors.

This bill requires pharmacy benefits managers to provide detailed financial reports to health plan sponsors every six months. The reports must include information about drug costs, payments, rebates, and out-of-pocket spending for each medication covered under the plan. The legislation affects pharmacy benefits managers, health plan sponsors, and drug manufacturers by mandating transparency in how these entities handle drug pricing and compensation. Reports must be presented in plain language and machine-readable formats to ensure plan sponsors can easily understand the financial details.
passed · New Jersey · General Assembly May 4, 2026

A 2199: Requires child abuse reporting hotline maintained by DCPP to provide information on resources available to victims and families.

This bill requires New Jersey's child abuse reporting hotline (maintained by the Division of Child Protection and Permanency) to provide callers with information about available resources for victims and their families. The hotline must now include details about community services such as counseling, parenting classes, substance abuse treatment, in-home support, foster care, and residential care. It directly affects families reporting or experiencing child abuse by connecting them to immediate support options. The policy change amends existing law to ensure victims and families are informed about these resources during hotline interactions.
passed · New Jersey · General Assembly May 4, 2026

A 2195: Directs DOH to develop guidelines for school districts and institutions of higher education concerning student vaping awareness campaigns.*

This bill requires New Jersey's Department of Health (DOH) and Department of Education (DOE) to create and distribute annual guidelines for school districts and colleges. The guidelines must include research-backed materials on vaping's health risks (lung effects, mental health, comparison to smoking, dangers to pregnant people and children), age-appropriate anti-vaping campaigns, decision-making tools to resist peer pressure, and promotional materials for students from middle school through college. Schools and colleges must use these guidelines to implement campus anti-vaping programs. The DOH and DOE will update the guidelines yearly and post them online with additional resources.
passed · New Jersey · General Assembly May 4, 2026

A 2205: Requires signs to be posted in emergency rooms regarding VCCO.

Bill A 2205 requires New Jersey's Commissioner of Health (working with the Attorney General) to create clear, easily understandable signs for emergency rooms. These signs must display VCCO services/benefits, contact details, and how to file a compensation claim. The bill mandates posting these signs in all general hospital emergency departments and satellite emergency departments, with electronic displays permitted. It aims to make VCCO information more accessible to individuals who may qualify for victim compensation after crimes. The bill takes effect four months after enactment.
passed · New Jersey · General Assembly May 4, 2026

A 1205: Requires Division of Developmental Disabilities to create and distribute satisfaction survey.

This bill requires New Jersey's Division of Developmental Disabilities to create and distribute a client satisfaction survey to individuals using support coordination services. The survey will rate agencies on a 1-5 star scale based on client feedback, with results updated quarterly and published online. Support coordination agencies - which help people with developmental disabilities access medical, social, and educational services - are directly affected by this new rating system. The policy mandates transparency in service quality without altering existing support structures.
in committee · New Jersey · General Assembly May 4, 2026

A 2181: Establishes requirements to evaluate certain people who are pregnant and who have given birth for endometriosis.

This bill requires New Jersey healthcare providers to refer pregnant people or new mothers diagnosed with preeclampsia who later show endometriosis symptoms for evaluation. It mandates obstetric care providers to educate patients about endometriosis, explain evaluation benefits, and either conduct the evaluation or refer for one (with a written refusal option). The Commissioner of Health must develop patient education materials on endometriosis symptoms and warning signs, in consultation with advocacy groups. If diagnosed, providers must create a treatment plan to minimize endometriosis risks. The bill is pending in committee and would take effect 180 days after enactment.
in committee · New Jersey · General Assembly May 4, 2026

A 2188: Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

This New Jersey bill (A 2188) requires birthing centers, federally qualified health centers, and healthcare providers offering prenatal or postpartum care (within 12 weeks of birth) to screen patients showing symptoms of high blood pressure during or after pregnancy for preeclampsia. Providers must use evidence-based tools from recognized medical groups, inform patients about symptoms and evaluation benefits, and discuss results - developing treatment plans if preeclampsia is confirmed. The law applies to people who haven’t been previously diagnosed with the condition in the current or recent pregnancy. It aims to standardize early detection and care for a serious postpartum health risk.
Showing 31 to 40 of 52 bills
Previous 1 … 3 4 5 … 6 Next